VEGFA and neoplasm: Another research from Bell’s group revealed that VEGF/VEGFR2 signaling in remodeling vessels could also sensitize the tumor vasculature to oncolytic VACVs infection by PRD1-BF1/Blimp1-mediated antiviral immune suppression (26).